MY167427A - Beverage, and method of producing the same - Google Patents

Beverage, and method of producing the same

Info

Publication number
MY167427A
MY167427A MYPI2015700273A MYPI2015700273A MY167427A MY 167427 A MY167427 A MY 167427A MY PI2015700273 A MYPI2015700273 A MY PI2015700273A MY PI2015700273 A MYPI2015700273 A MY PI2015700273A MY 167427 A MY167427 A MY 167427A
Authority
MY
Malaysia
Prior art keywords
beverage
angiogenin
degradation product
rheumatism
osteoporosis
Prior art date
Application number
MYPI2015700273A
Inventor
Aiko Ohmachi
Yuko Ishida
Takayuki Nara
Hiroshi Urazono
Hiroaki Matsuyama
Yoshikazu Morita
Ken Kato
Atsushi Serizawa
Hiroshi Ueno
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Priority to MYPI2015700273A priority Critical patent/MY167427A/en
Publication of MY167427A publication Critical patent/MY167427A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

THE PRESENT INVENTION ADDRESSES THE PROBLEM OF PROVIDING A SAFE AND NOVEL BEVERAGE WHICH IS USEFUL IN THE PREVENTION AND TREATMENT OF VARIOUS BONE DISORDERS SUCH AS OSTEOPOROSIS, BONE FRACTURES, RHEUMATISM, AND ARTHRITIS WHEN TAKEN ON A DAILY BASIS. A BEVERAGE CONTAINING MORE THAN 0.8 MG/100 ML AND 150 MG/100 ML OR LESS OF ANGIOGENIN AND/OR AN ANGIOGENIN DEGRADATION PRODUCT, AND LACTOPEROXIDASE AND/OR A LACTOPEROXIDASE DEGRADATION PRODUCT AT A MASS RATIO OF 0.3 TO 23 RELATIVE TO THE ANGIOGENIN AND/OR ANGIOGENIN DEGRADATION PRODUCT. IT IS POSSIBLE TO STRENGTHEN BONES AND TO PREVENT AND TREAT VARIOUS BONE DISORDERS SUCH AS OSTEOPOROSIS, BONE FRACTURES, RHEUMATISM, AND ARTHRITIS BY TAKING SAID BEVERAGE.
MYPI2015700273A 2012-07-31 2012-07-31 Beverage, and method of producing the same MY167427A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2015700273A MY167427A (en) 2012-07-31 2012-07-31 Beverage, and method of producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2015700273A MY167427A (en) 2012-07-31 2012-07-31 Beverage, and method of producing the same

Publications (1)

Publication Number Publication Date
MY167427A true MY167427A (en) 2018-08-28

Family

ID=64277953

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015700273A MY167427A (en) 2012-07-31 2012-07-31 Beverage, and method of producing the same

Country Status (1)

Country Link
MY (1) MY167427A (en)

Similar Documents

Publication Publication Date Title
MX2018012655A (en) Compounds and methods for treating neurological and cardiovascular conditions.
MX2018002507A (en) Method for inhibiting absorption of and/or promoting excretion of lipids using d-psicose.
PH12015500049A1 (en) Novel portein material
MX2020006237A (en) Compounds for treatment of diseases related to dux4 expression.
EP3712264A8 (en) Cystathionine beta-synthase enzyme for treatment of homocystinuria
MX356755B (en) Fumigillol type compounds and methods of making and using same.
IN2014DN08215A (en)
PH12015500051A1 (en) Novel fermented milk product and method for producing the same
WO2018178243A3 (en) Dihydrotetrabenazine for use in the treatment a movement disorder
WO2015059463A3 (en) Treatment of beta-catenin related diseases8
EP3603657A4 (en) Composition containing amomum villosum extract for prevention, alleviation, or treatment of obesity
MX2015001344A (en) Fermented milk product, and method for producing same.
NZ700546A (en) Use of neuregulin to treat peripheral nerve injury
MX2013002118A (en) Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators.
MX2015005733A (en) Tricyclic compounds for use in the treatment and/or control of obesity.
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
PH12015500052A1 (en) Novel powdered milk product and method for producing the same
PH12015500053A1 (en) Novel cheese and method for producing the same
PH12015500048B1 (en) Novel protein material
GB2530226A (en) Chewable tablet
MY167427A (en) Beverage, and method of producing the same
PH12015500050A1 (en) Beverage, and method of producing the same
MY181546A (en) Beverage, and method of producing the same
NZ704919A (en) Powdered milk product, and method for producing same
MY167429A (en) Novel cheese and method for producing the same